Multi-Action Coatings – Straightforward Solutions for Complex Challenges

Medical devices face complex biocompatible challenges when innovating modern therapies. Multi-action coatings confront these complex challenges in one straightforward, high-performance technology which enhances device performance and improves patient well-being.

BioInteractions have developed three unique polymer coatings to help with these challenges:

Astute®Anti-thrombogenic Coating

Active-Endothelial Action

Astute® uses an active anti-thrombogenic agent bound within its polymer backbone in combination with passive components to block thrombus formation, mimic endothelial layer and reduce further risks to the patient.


Astute® Active-Endothelial Action:

  • Actively stops blood activation
  • Prevents protein and cellular deposition
  • Non-leaching and stable for long-term applications

AvertPlus™ Antimicrobial Coating

Long lasting, Contact-Kill Mechanism

AvertPlus™ reduces device related infections and targets biofilm formation through a contact-kill mechanism paired with passive components. This non-leaching combination instantly kills bacteria without the use of toxic components, protects the device surface from bacteria and consistently reduces infection in patients.


AvertPlus™ Long lasting, Contact Kill Mechanism:

  • Actively disrupt broad-spectrum of bacteria to result in lysis
  • Prevents deposition and adhesion of proteins
  • Non-leaching, non-toxic components for long term applications

Assist™ Hydrophilic Coating

Flexible and Durable Assistance

Assist™ significantly reduces friction and minimises obstacles faced at the device-body interface. The highly hydrophilic surface improves insertion and removal of devices, enhances surface smoothness to reduce adhesion and shields the device from deposition.


Assist™ Enhanced Lubricity:

  • Significantly reduces friction and shields the surface
  • Flexible, non-cytotoxic and stable for long term applications
  • Available as UV Cured or Heat Cured for application on various shapes and materials

Your All-In-One Coating Partner

BioInteractions manufactures all our coating technology in-house and supports our customers efforts with our customer focused Commitment to Care (C2C) services. Our high-performance, multi-action coating technology offers our partners the ability to confront complex biocompatible challenges with a straightforward solution and enhance the performance of their device.


Our expertise has been collected in our C2C services to supports partners’ through their development process. These services consider the challenges with the application of the coating onto the device, the data required for regulatory submission as well as coating services for commercial devices.


We combine high-performance, multi-action technology with customer focused services to ensure the highest quality coated devices are supplied to patients and to help our partners have confidence in our support in their innovation of enhanced devices. We are committed to maintain our quality throughout our high-performance, multi-action coating technology as well as customer focused support services to enable patients to access breakthrough therapies with the highest quality of coated devices.

Back To Top 

Go to article: Home | A new frontier for robotic surgeryGo to article: In this issueGo to article: ContentsGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Pulse Technologies Company InsightGo to article: Pulse TechnologiesGo to article: Watlow Company InsightGo to article: WatlowGo to article: AccumoldGo to article: CommentGo to article: Wearable technology for cardiology expands with RhythMedixGo to article: Insightin Health aims to use AI to reduce healthcare costsGo to article: The effect of skin pigmentation on pulse oximeter resultsGo to article: Tidepool Loop and the future of digital diabetes careGo to article: 3D printing of drugs can revolutionise personalised medicine and improve sustainGo to article: ElectroCraftGo to article: ProByLas Go to article: Smiths InterconnectGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DepthGo to article: How can smaller medtech companies protect their IP?Go to article: Medical video games: Level Ex enters the pharma-sales relationshipGo to article: Robotic gynaecology: a new frontier in surgery launches in LondonGo to article: WheezeScan: device sparks hope for detecting asthma attacks in under-fivesGo to article: Medicine music: how an earbud could treat arthritis and migrainesGo to article: Kar-go: could an autonomous robot be the new face of drug transport?Go to article: The game-changing potential of digital therapeutics with Dr Brennan SpiegelGo to article: Can AI predict depression?Go to article: HirLan Company InsightGo to article: HirLanGo to article: Photonic Company InsightGo to article: Photonic Go to article: Asahi InteccGo to article: In DataGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next Issue